Anzalee Khan, PhD
- 4Articles
- 17.8KReads
- 2007–2018Active
- 21Collaborators
- 115Citations
About
Anzalee Khan, PhD, has published extensively on schizophrenia and schizoaffective disorders, with a focus on cognitive effects and treatment of negative symptoms. Research topics include the impact of antipsychotic medications such as olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenia, as well as evaluations of structured wellness programs for patients with severe mental illness. Khan’s work spans clinical trials comparing antipsychotic efficacy and metabolic outcomes. Publications appeared between 2007 and 2018 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
